This comprehensive guide explores the critical role of Pharmacokinetic/Pharmacodynamic (PK/PD) modeling in accelerating and de-risking drug development.
This article provides a comprehensive guide for researchers, scientists, and drug development professionals on the critical role of Pharmacokinetic/Pharmacodynamic (PK/PD) modeling in the validation of pharmacodynamic (PD) biomarkers.
This article provides a detailed exploration of the PI3K/Akt signaling pathway as a central regulator of cell survival and apoptosis inhibition, crucial for cancer biology and targeted therapy.
This article provides a comprehensive review for researchers and drug development professionals on the critical challenge of using positron emission tomography (PET) with radiolabeled antibodies for central nervous system targets.
This article provides a comprehensive comparison of Physiologically Based Pharmacokinetic (PBPK) modeling and allometric scaling for predicting human first-pass metabolism during drug development.
This article provides a comprehensive guide for researchers and drug development professionals on leveraging Physiologically Based Pharmacokinetic (PBPK) modeling to predict first-pass metabolism.
This article provides a comprehensive guide for drug development professionals on the application of Physiologically-Based Pharmacokinetic (PBPK) modeling for predicting pharmacokinetic (PK) properties directly from molecular structure.
This article provides a thorough exploration of Physiologically Based Pharmacokinetic (PBPK) modeling as a transformative tool for pediatric drug development.
This article provides a comprehensive guide for researchers and drug development professionals on the application of Physiologically-Based Pharmacokinetic (PBPK) modeling for patients with organ impairment in clinical trials.
This article provides a detailed guide to Physiologically Based Pharmacokinetic (PBPK) modeling for oral Selective Estrogen Receptor Degraders (SERDs).